Filter posts

BIO Principles on Expanded Access to Investigational, Unapproved Medicines

Seriously ill patients with limited or no alternative therapies, and who are ineligible or unable …

Dr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards Program

Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes …

Coalition Offers a Remedy for Stagnated Clinical Trials

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A …

What to Watch: Emperor of All Maladies; Killing Cancer

Cancer is a disease which affects almost 1.7 million people each year in America, and …

Webinar Today: Comparative Effectiveness Research

As we continue to see new strides in biopharmaceutical innovation, there is increasing value in …

The Value of Innovation to Save and Transform Lives

Patients have greater hope for cures to today’s most complex and challenging diseases thanks to …

We Need Your Input: BIO Survey on Effective FDA-Sponsor Communication

BIO is surveying members and non-members on their interactions with the FDA during the various …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

Getting Ready for #RDD2015 (Rare Disease Day 2015)

Rare Disease Day is just around the corner on February 28th. R&D investment into rare …

Biotech Could Miss a Multi-Billion Dollar Opportunity in Rare Disease

Drug development is expensive.  Drug development is risky.  Drug development takes a long time. The …